(Xbox) X-Men 2: Wolverine’s Revenge

10.53 £

Sun 7th Jun, 2026 - Thu 18th Jun, 2026

⌄

Sun 7th Jun, 2026 - Thu 18th Jun, 2026

⌄

Featuring an original story line written exclusively for Activision by comics industry legend Larry Hama, and featuring the voices of Mark Hamill and Patrick Stewart, X-Men: Wolverines Revenge lets players take on the role of Wolverine, everyones favourite X-Men tough guy. In the game, Wolverine faces a race against time to find an antidote to the viral time bomb thats just been discovered in his system. With only 48 hours to live, Wolverine returns to the clandestine Department H facility deep in the Canadian wilderness, to uncover the terrible secrets behind the Weapon X laboratory and the experiments that turned the mutant hero into a precision killing machine. As with all mutants, Wolverine has unique abilities that set him apart from the rest of humanity--deadly claws to defeat the greatest of foes, animal-like super senses to assist in tracking enemies, an enhanced mutant healing factor, unbreakable bones to withstand devastating amounts of punishment and superior strength and reflexes for an added edge in combat. In X-Men: Wolverines Revenge players will have to master all of these skills in order to defeat the sinister forces massing against them led by arch-villains Juggernaut, Wendigo, Magneto and Sabertooth. Luckily, players wont have to face the onslaught alone and can expect occasional backup from fellow X-Men including Professor-X and Beast. Youve read the comic, youve seen the film--now be the mutant X-Men 2: Wolverines Revenge puts you in the adamantium-spiked shoes of the X-Mens meanest hero. While comics are having a bit of renaissance in films lately, with several decent versions of four-colour heroes making it to the big screen, the only half-decent superhero game is still Spider-Man. Wolverine

Our Compliance with European Law⌄

GPSR

This product was made available on the market before 13th December 2024 and therefore Article 51 applies:

Article 51

Member States shall not impede the making available on the market of products covered by Directive 2001/95/EC which are in conformity with that Directive and which were placed on the market before 13th December 2024.